Article Text

Download PDFPDF

Low dose steroids and clinical relapse in Crohn's disease: a controlled trial.
  1. R C Smith,
  2. J Rhodes,
  3. R V Heatley,
  4. L E Hughes,
  5. D L Crosby,
  6. B I Rees,
  7. H Jones,
  8. K T Evans,
  9. B W Lawrie


    The long-term effect of prednisone in Crohn's disease has been examined in a double-blind controlled trial. Clinical relapse, recurrence, and extension of the disease were examined in 64 patients followed-up for up to three years. Fourteen patients were withdrawn because of severe symptoms (eight on prednisone and six controls); the withdrawal rate in both groups was 30% at three years. Nine other patients had radiological recurrence or extension of disease (five prednisone and four controls). Prednisone did not improve the relapse rate, nor did it affect recurrence or extension of disease.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.